Table 5

Overexpression of erbB-2 versus chemotherapy response tumors with amplification excluded

For the 27 patients who did not have erbB-2 amplification, there was no evidence of an association between erbB-2 overexpression and tumor response (P = 0.843). Response was determined by comparison of the breast tumor at presentation with the mastectomy specimen.

CR or MRDPRSTD or PD
erbB-2 overexpressed162
erbB-2 not overexpressed2106
Total patients3168